Allometric prediction of the human pharmacokinetic parameters for naveglitazar
โ Scribed by Preeti Ahlawat; Nuggehally R. Srinivas
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 475 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0378-7966
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The objectives of this study are: (i) to evaluate the predictive performance of interspecies scaling for antibodies to predict clearance, volume of distribution at steady state, and half-life in humans from animal data and (ii) to estimate first-inhuman dose based on the predicted human clearance. F
The goal of quantitative structure-pharmacokinetic relationship analyses is to develop useful models that can predict one or more pharmacokinetic properties of a particular compound. In the present study, a multiple-output artificial neural network model was constructed to predict human half-life, r
Allometrically scaled data sets (138 compounds) used for predicting human clearance were obtained from the literature. Our analyses of these data have led to four observations. (1) The current data do not provide strong evidence that systemic clearance (CL(s); n = 102) is more predictable than appar